Facilitating European Clinical Research

ECRIN is a public, non-profit organisation that links scientific partners and networks across Europe
to facilitate multinational clinical research. We provide sponsors and investigators with advice,
management services and tools to overcome hurdles to multinational trials and enhance collaboration.

Our Work

We provide our 11 Member and Observer Countries with diverse trial support services
and contribute to other capacity building projects with additional European and international partners.

ECRIN in Numbers

Member & Observer Countries

Million citizens represented

Trials in ECRIN portfolio

Average # of countries per trial

Events

Date:

HEALTH NCP-Net 2.0 is jointly organising (with BBMRI-ERIC, EATRIS-ERIC, ECRIN and ELIXIR) a webinar to learn about the aims and activities of these research infrastructures (RIs) and how to involve and benefit from them within a Horizon 2020 project.

The second part will be a Q&A session.

Presenters:

  • Francesco Florindi - Engagement officer, BBMRI
  • Anne-Charlotte Fauvel - Head of European Projects, EATRIS
  • Jacques Demotes - Director General, ECRIN
  • Juan Arenas - Head of the Project Management Unit, ELIXIR


When: Tuesday 22nd January 2019, from 15:30 to 16:45 CET

Due to the fact that there are limited places available and participation will be on a “first come first served basis”, registration will close when maximum number of participants will be reached.

Register here until 18 January 2019

Date:

The EFGCP Annual Conference 2019 focuses on achieving better integration of clinical research in healthcare.

Many scientific, methodological and regulatory challenges in research and development of treatments for different diseases have been successfully overcome in the past years. However, in order to reach the ultimate ethical objective of ensuring patient centricity in treatment development, changes must be envisaged in our healthcare environment, in clinical research concepts, in the digital environment, in the way stakeholders collaborate, in the healthcare professionals’ knowledge and attitude towards new treatments development, in the requirements of competent authorities and payers, and in funding strategies. 

Conference sessions will include:

•    Clinical trials and novel Research & Development strategies
•    Patient-driven initiatives for a roadmap to health
•    The need for different protocol designs and concepts
•    The optimal use of other available data sources

For more information, visit the EFGCP website

Date:

SY-Stem, a symposium focusing on the next generation of stem cell researchers, is an annual meeting in Vienna. It is jointly organised by the Research Institute of Molecular Pathology (IMP) and the Institute of Molecular Biotechnology (IMBA).

During the event, recognised keynote speakers as well as aspiring young group leaders will discuss the latest advances in stem cell biology in an informal and collaborative setting. 

The 2019 sessions include the following topics:

  • Adult stem cells
  • Germ lines & totipotency
  • Organoids
  • Pluripotency, differentiation & reprogramming
  • Regeneration & ageing

For more information, click here